'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

  title={'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease \& end-stage renal disease in the United States.},
  author={A. Collins and R. Foley and B. Chavers and D. Gilbertson and C. Herzog and K. Johansen and B. Kasiske and N. Kutner and Jiannong Liu and W. S. St. Peter and Haifeng Guo and S. Gustafson and B. Heubner and Kenneth Lamb and Shuling Li and Suying Li and Yi Peng and Yang Qiu and T. Roberts and M. Skeans and J. Snyder and C. Solid and B. Thompson and C. Wang and E. Weinhandl and D. Zaun and Cheryl Arko and Shu-cheng Chen and F. Daniels and J. Ebben and E. Frazier and Christopher Hanzlik and Roger Johnson and Daniel Sheets and Xinyue Wang and B. Forrest and E. Constantini and S. Everson and P. Eggers and L. Agodoa},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  volume={59 1 Suppl 1},
          A7, e1-420
  • A. Collins, R. Foley, +37 authors L. Agodoa
  • Published 2012
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies
1. Guideline Development Group: Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 mL/min) and clinical practice guidance on management after renal biopsy on patients with diabetic nephropathy. Expand
Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study.
Acarbose used in real-world T2D patients with ESRD may have hepatic and cardiovascular safety, and the favorable study outcomes of acarbose use were more apparent among patients with more severe diabetes, a longer diabetes duration, or absence of established CVD at baseline. Expand
Clinical Outcomes in Asian Elderly Kidney Transplant Recipients : A Multicenter Cohort Study
K.D. Yoo, J.N. An, C.T. Kim, J.H. Cho, C.D. Kim, S.K. Park, D.W. Chae, Y.K. Oh, C.S. Lim, Y.S. Kim, Y.H. Kim*, and J.P. Lee* Department of Internal Medicine, Seoul National University College ofExpand
Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
eGFR reporting was associated with small reductions in late referral, but more than 1 in 5 patients are still referred late, and there was no impact on initial RRT modality or prepared access rates at hemodialysis therapy initiation between eras. Expand
Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service
This is the first comprehensive view, with no exclusions, of CKD patients seen in a public renal specialty referral practice, in Australia, and it dictates a need for a wider scope of health services provision incorporating multiple models of care. Expand
Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry–publication on behalf of Taiwan Society of Nephrology
This is the first report of the National Renal Biopsy Registry in Taiwan, and IgA nephropathy is the most common primary glomerulonephritis, while membranous nephopathy isThe most common cause of nephrotic syndrome. Expand
Clinical and genetic associations of renal function and diabetic kidney disease in the United Arab Emirates: a cross-sectional study
Objectives Within the Emirati population, risk factors and genetic predisposition to diabetic kidney disease (DKD) have not yet been investigated. The aim of this research was to determine potentialExpand
End-stage renal disease and survival in people with diabetes: a national database linkage study
Considerable numbers of patients with diabetes continue to progress to CKD5 and RRT, and Median survival time for people with diabetes from initiation of RRT remains poor. Expand
Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry
Estimates indicate that USRDS-based studies may underreport ESRD among US patients with SLE, but observed patterns of differential attribution of ESRd cause, particularly by age, suggest that providers may be correctly attributing E SRD to causes other than SLE among some patients withSLE. Expand
Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease
The review addresses issues related to end-of-life support, the importance of Apolipoprotein-1 gene variants, and the advent of pharmacogenomics toward achieving precision care in ESRD care for AAs. Expand